Merck KGaA (OTCMKTS:MKGAF) Shares Up 7.6% – Time to Buy?

Merck KGaA (OTCMKTS:MKGAF – Get Free Report) shares traded up 7.6% during mid-day trading on Monday . The stock traded as high as $140.4690 and last traded at $140.4690. 152 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 888 shares. The stock had previously closed at $130.55.

Merck KGaA Price Performance

The firm has a market capitalization of $18.28 billion, a P/E ratio of 21.60 and a beta of 0.96. The business’s fifty day moving average is $134.00 and its 200 day moving average is $131.64. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Further Reading

• Five stocks we like better than Merck KGaA
• How Can Investors Benefit From After-Hours Trading
• If D-Wave Is Too Risky, Consider These 3 Quantum ETFs for Diversification
• Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
• NVIDIA’s 13F Reveals 2 Q3 Winners—And 1 Painful Miss
• About the Markup Calculator
• Why Silver Beat Gold and the S&P in 2025—And What Comes Next